ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle.
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Jason H Y
JH
Wu
Dariush
D
Mozaffarian
D050197:Atherosclerosis / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D018450:Disease Progression; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans
D015525:Fatty Acids, Omega-3
Coronary Artery Disease